Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Impaired work ability, Myalgia, Vomiting
Clinical narrative: Unable to work for much of the time since she got the vaccine; pain in the back, shoulder, knee; joint pain/residual joint pain that seemed to be flared up by the vaccine back in March; achiness; fatigue; headache; vomiting; stomach pain; dizziness; This spontaneous case was reported by a physician assistant and describes the occurrence of ABDOMINAL PAIN UPPER (stomach pain), DIZZINESS (dizziness), IMPAIRED WORK ABILITY (Unable to work for much of the time since she got the vaccine), BACK PAIN (pain in the back, shoulder, knee) and ARTHRALGIA (joint pain/residual joint pain that seemed to be flared up by the vaccine back in March) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concurrent medical conditions included Blood pressure high, Allergy to antibiotic (Amoxicillin), Drug allergy (Benadryl), Drug allergy (Ibuprofen), Latex allergy, Drug allergy (Lisinopril) and Drug allergy (Toradal). Concomitant products included CHLORTHALIDONE for Blood pressure management, LOSARTAN for an unknown indication.    On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Mar-2021, the patient experienced ABDOMINAL PAIN UPPER (stomach pain), DIZZINESS (dizziness), ARTHRALGIA (joint pain/residual joint pain that seemed to be flared up by the vaccine back in March), MYALGIA (achiness), FATIGUE (fatigue), HEADACHE (headache) and VOMITING (vomiting). On 21-Apr-2021, the patient experienced BACK PAIN (pain in the back, shoulder, knee). On an unknown date, the patient experienced IMPAIRED WORK ABILITY (Unable to work for much of the time since she got the vaccine). The patient was treated with DICLOFENAC (topical) on 09-Apr-2021 at a dose of 1 %; CELECOXIB (CELEBREX) on 12-Apr-2021 at a dose of 200 milligram once a day; AMITRIPTYLINE (AMITRIPTILIN) at a dose of 10 milligram once a day; BACLOFEN for Muscle ache, at a dose of 10 milligram three times a day; DULOXETINE for Chronic pain, at a dose of 60 milligram once a day and TIZANIDINE for Muscle ache, at a dose of 2 milligram every eight hours. At the time of the report, ABDOMINAL PAIN UPPER (stomach pain), DIZZINESS (dizziness), MYALGIA (achiness), FATIGUE (fatigue), HEADACHE (headache) and VOMITING (vomiting) was resolving and IMPAIRED WORK ABILITY (Unable to work for much of the time since she got the vaccine), BACK PAIN (pain in the back, shoulder, knee) and ARTHRALGIA (joint pain/residual joint pain that seemed to be flared up by the vaccine back in March) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 12-Apr-2021, C-reactive protein: 10 (High) Greater than 10. On 21-Apr-2021, C-reactive protein: 8.1 (abnormal) Significantly 8.1. On 01-May-2021, C-reactive protein: 7.7 (abnormal) 7.7.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient prescribed with occupational medicine.  Patient last visited to Health care professional on 11 JUN 2021 on phone.   Most recent FOLLOW-UP information incorporated above includes: On 21-Jul-2021: Follow- up received. Patient demographics were added, Allergies were added and additional events Impaired work ability and Joint pain were added